Clinical and Economic Characteristics of Patients with Painful Neuropathic Disorders in Germany

Abstract

Using a large database with information from general practitioners (GP) throughout Germany, we identified all adults (age ≥18 years) with encounters for painful neuropathic disorders (PNDs) between August 1, 2005 and July 31, 2006 (PND patients). We also constituted an age‐ and sex‐matched comparison group, consisting of randomly selected patients without any GP encounters for PNDs during the same period. Selected characteristics were then compared between PND patients and those in the comparison group over the 1‐year study period. The study sample consisted of 275,685 PND patients and a similar number in the matched comparison group; mean age was 53.7 years, and 57% were women. PND patients were more likely than matched comparators to have encounters for various comorbidities, including circulatory system disorders (47% vs. 20%, respectively), depression (9% vs. 2%), and anxiety (4% vs. 1%) (all P < 0.01). They also were more likely to have received pain‐related medications (57% vs. 13% for comparison group; P < 0.01)—most commonly, nonsteroidal anti‐inflammatory drugs, benzodiazepines, and opioids, and less often, tricyclic antidepressants and anti‐epileptics. PND patients averaged 7.3 more GP visits during the year (mean [95% CI] = 9.9 [9.9, 9.9] vs. 2.6 [2.6, 2.7] for comparison group); they also had significantly more specialist referrals and physician‐excused absences from work (all P < 0.01). Patients with PNDs under the care of GPs in Germany have comparatively more comorbidities and higher levels of use of healthcare services. The pain‐related medications that these patients receive raise concerns that PNDs may not be optimally treated in these settings.